Full-Time

Patient Education Consultant

Posted on 8/17/2026

Tactile Medical

Tactile Medical

1,001-5,000 employees

Markets at-home pneumatic compression therapies

Compensation Overview

$23.89 - $34.48/hr

Baltimore, MD, USA

Remote

Travel up to 80% within the assigned territory is required.

Bachelor's

Category
Training
Required Skills
Sales
HIPAA
Patient Education

Get referred to Tactile Medical

See people who can refer or advise you

Requirements
  • A Bachelor's Degree or equivalent work experience is required.
  • At least 2 years of experience in a patient-facing, education/training, and/or highly advanced customer service role is required.
  • The ability to lift 20 pounds on a regular basis is required.
  • The ability to work remotely and travel to patients in home, clinic, or virtual environments is required.
  • Clear written and verbal communication with patients, caregivers, field staff, and internal teams is required.
  • Strong interpersonal communication skills, including the ability to empathize with patients and caregivers, are required.
  • Strong critical thinking and decision-making skills in healthcare-related situations are required.
  • Confidence and professionalism when interacting with people of diverse cultures, ages, and abilities are required.
  • Strong organization and time-management skills for scheduling and managing multiple appointments are required.
  • The ability to apply information from online learning modules and virtual or in-person interactions to enhance the patient experience is required.
  • Skill in teaching others is required.
  • The ability to remain focused and organized while completing assigned tasks is required.
  • Technology proficiency for completing paperwork, updating records, and communicating progress is required.
  • The ability to work independently and remain self-directed is required.
Responsibilities
  • Educate patients and caregivers on all aspects of device use, including donning and doffing garments, using the controller, following prescribed protocols, and initiating therapy sessions.
  • Contact patients within service-level expectations to schedule and complete trainings and demonstrations.
  • Conduct direct sales to patients by explaining financial responsibility, insurance coverage, and finalizing sales.
  • Provide clear verbal instruction during patient demonstrations and trainings, adapting the approach to each patient's needs.
  • Manage and respond appropriately to positive and negative patient feedback or objections regarding the product, financial responsibility, and required paperwork.
  • Prepare for trainings and demonstrations by confirming appointment details and gathering necessary equipment, supplies, documentation, and accessories.
  • Review, complete, and submit required paperwork with patients and answer their questions.
  • Work collaboratively with territory partners to facilitate order completion, including collecting signatures on prescriptions or other documents required for insurance.
  • Identify, escalate, and communicate problems, questions, and additional patient-support needs to the appropriate department.
  • Use translation tools for patients whose first language is not English.
  • Meet or exceed established performance expectations.
  • Maintain compliance with applicable regulatory requirements, including HIPAA.
  • Travel up to 80% within the assigned territory.
  • Perform other duties as assigned.
Desired Qualifications
  • A health-related certification is preferred.
  • Experience in the medical-device or healthcare industry is preferred.

Tactile Medical develops at-home pneumatic compression devices for chronic swelling conditions such as lymphedema, lipedema, and chronic venous insufficiency. Its main products, Flexitouch Plus and Nimbl, provide controlled air pressure to limbs to stimulate the lymphatic system and reduce swelling, for home use with clinical education and support. The company differentiates itself by offering a full continuum of care—home-based treatment with ongoing education and customer service—rather than relying only on clinic visits. Its goal is to improve quality of life for patients with underserved chronic vascular conditions, and it trades on Nasdaq under the ticker TCMD.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Minneapolis, Minnesota

Founded

1995

Get referred to Tactile Medical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue rose 9% to $85.7 million; EBITDA reached $11.4 million.
  • August 10, 2026 guidance stayed strong at $360-$366 million revenue and $49-$51 million EBITDA.
  • Medicare channel sales jumped 40% after prior authorization, validating Tactile's workflow advantage.

What critics are saying

  • August 10, 2026 AffloVest revenue still fell 7%; inventory issues persist.
  • July 2026 MyoSleeve needs minimum purchases and $3 million upfront, pressuring returns.
  • April 13, 2026 Medicare prior authorization slows pump starts; settlement risk followed July 2026.

What makes Tactile Medical unique

  • Tactile Medical owns Flexitouch Plus, Nimbl, and MyoSleeve across chronic swelling care.
  • July 13, 2026 MyoSleeve deal adds VA-DoD access and non-pneumatic compression.
  • June 2, 2026 AffloVest launch adds connected airway-clearance hardware and data capture.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Parental Leave

Disability Insurance

Life Insurance

Employee Stock Purchase Plan

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 18th, 2026
Tactile Systems Technology reports 9% revenue growth to $85.7M in Q2 2026

Tactile Systems Technology reported second quarter 2026 results with total revenue of $85.7 million, up 9% year-over-year. The medical device company's lymphedema business drove growth with revenue of $73.6 million, representing a 12% increase from the prior year. Chief executive officer Sheri Dodd highlighted the company's strong execution and profitability expansion during the quarter. AffloVest revenue totalled $12.1 million, declining 7% year-over-year. The company attributed the AffloVest decline to temporary inventory management issues among large durable medical equipment partners. These dynamics were associated with the launch of a next-generation AffloVest system during the quarter. Chief financial officer Elaine Birkemeyer joined Dodd on the earnings call. The company's lymphedema business continued to demonstrate strength, offsetting challenges in its respiratory care product line.

Yahoo Finance
Aug 11th, 2026
Tactile Systems beats Q2 estimates with $0.34 EPS and $85.7M revenue

Tactile Systems Technology reported second-quarter earnings of $0.34 per share, significantly beating the Zacks Consensus Estimate of $0.14 per share. This represents an earnings surprise of 142.86%, compared to $0.14 per share a year ago. The medical device maker posted revenues of $85.7 million for the quarter ended June 2026, surpassing the consensus estimate by 0.19%. This compares to year-ago revenues of $78.9 million. The company has exceeded consensus earnings estimates three times over the last four quarters and topped revenue estimates in all four quarters. Tactile Systems Technology shares have gained 1.7% year-to-date, underperforming the S&P 500's 13.3% gain. The stock currently holds a Zacks Rank of Hold.

Associated Press
Jul 13th, 2026
Tactile Medical secures exclusive US distribution for ElastiMed's MyoSleeve compression device

Tactile Medical has entered an exclusive US distribution agreement with ElastiMed for MyoSleeve, a wearable compression device for lower leg treatment, targeting Department of Veterans Affairs and Department of Defense patients. The company made a $3 million upfront payment to ElastiMed and committed to minimum purchase obligations. MyoSleeve uses electroactive polymer technology to deliver dynamic compression through flexible bands worn around the calf beneath clothing. The battery-powered device operates without tubing or external controllers, providing therapy during daily activities. The device has received FDA 510(k) clearance for treating chronic swelling, including chronic oedema, lymphoedema, and venous insufficiency. It is designed for patients in earlier stages of chronic swelling who may not require intensive compression therapy. Tactile Medical will leverage its sales organisation and patient support infrastructure to commercialise MyoSleeve within the VA and DoD systems.

SAHM Capital
Jul 13th, 2026
Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve(TM) Wearable Compression Device for VA and DoD Patients

Tactile Medical enters exclusive U.S. Distribution agreement with ElastiMed for its MyoSleeve(TM) wearable compression device for VA and DoD patients. Tactile Systems Technology -2.67% Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression MINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) - Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced it has entered into an exclusive distribution agreement with ElastiMed, Inc. to bring MyoSleeve(TM), its discreet, wearable non-pneumatic compression device for the lower leg, to Department of Veterans Affairs (VA) and Department of Defense (DoD) patients across the United States. MyoSleeve expands Tactile Medical's established market-leading portfolio by providing a new treatment option for appropriately selected patients in earlier stages of chronic swelling who may not yet require more intensive compression therapy. MyoSleeve may also be appropriate as a complementary treatment to a traditional pneumatic compression device and for patients who struggle with conservative therapy, or those with mobility-limiting cases. Wrapped around the calf with the ability to be worn beneath clothing, MyoSleeve uses electroactive polymer technology to deliver dynamic compression through flexible bands that contract in sequence. The battery-powered device is designed as an all-in-one therapy option, operating without tubing, cords, or an external controller, and quietly delivers intermittent therapy while patients go about daily activities. MyoSleeve has received U.S. Food and Drug Administration 510(k) clearance and is indicated for the treatment of chronic swelling, including chronic edema, lymphedema, and venous insufficiency. Under the agreement, Tactile Medical holds exclusive U.S. distribution rights for MyoSleeve within the VA and DoD systems. In connection with these exclusive distribution rights, the Company made an upfront payment of $3 million to ElastiMed. The Company also committed to certain minimum purchase obligations and marketing and sales promotion as it supports ElastiMed's growth. The Company expects to leverage its established sales organization, billing and payment expertise, and patient support infrastructure to drive MyoSleeve commercialization and support ongoing market access initiatives. MyoSleeve is available by prescription, and appropriate patient selection is determined by the treating clinician. "Our agreement with ElastiMed adds a differentiated, wearable compression option to Tactile Medical's portfolio and reflects our strategy of expanding access to patient-focused solutions across the continuum of chronic swelling care," said Sheri Dodd, Chief Executive Officer of Tactile Medical. "For the right patient, MyoSleeve offers unobtrusive compression therapy that fits into daily life, giving patients the freedom to stay mobile while engaged in their own care." "Partnering with Tactile Medical gives MyoSleeve a direct path to certain patients with chronic swelling who want to stay active while getting the treatment they need," said Omer Zelka, Chief Executive Officer of ElastiMed. "It is the first ambulatory all-in-one, cable-free, clinical-grade solution for patients with venous and lymphatic conditions. This partnership enables the first commercial introduction of MyoSleeve through a trusted and market-leading medical device partner." "Compression therapy is not one-size-fits-all. Clinicians achieve the best outcomes when they have a range of options that can be matched to disease severity, anatomy, and lifestyle," said Tony Gasparis, MD, Chief Medical Officer of Tactile Medical. "MyoSleeve introduces an important new option for appropriately selected patients with lower-leg swelling, offering active compression that is well-suited for earlier stages of disease, where consistent therapy adherence is key to slowing disease progression. Importantly, MyoSleeve is designed to complement - not replace - advanced pneumatic compression therapies, which remain the standard of care for patients with more extensive or advanced disease." About Tactile Systems Technology, Inc. (DBA Tactile Medical) Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic inflammatory lung disease by helping them live better and care for themselves. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year. About ElastiMed, Inc. ElastiMed is a commercial-stage medical device company developing wearable therapeutic devices based on electroactive polymer (EAP) technology, designed to deliver dynamic compression in a comfortable, low-profile, and easy-to-use form. Investor Inquiries: Sam Bentzinger Gilmartin Group [email protected] This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Ticker Report
Jul 2nd, 2026
Inspire Investing LLC Makes New Investment in Tactile Systems Technology, Inc. $TCMD

Inspire Investing LLC bought a new position in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) in the first quarter, Holdings Channel.com reports. The fund bought 59,794 shares of the company’s stock, valued at approximately $1,562,000. A number of other hedge funds have also modified their holdings of TCMD. Russell Investments Group Ltd. […]